Temasek-backed Manipal Health Enterprises Limited will launch its Initial Public Offering (IPO) on July 29, 2026, closing on July 31, 2026. The price band is set at ₹560 to ₹590 per share, seeking to raise over ₹9,270 crore. Proceeds will focus on deleveraging and corporate expansion.
BENGALURU, India — Manipal Health Enterprises Limited, India's second-largest hospital operator by bed capacity, will launch its initial public offering (IPO) for public subscription on July 29, 2026. The subscription window will remain open for three days, closing on July 31, 2026.
The company has fixed the equity share price band between ₹560 and ₹590 per share, setting the stage for one of the country's largest healthcare market entries this year.
Issue Details and Valuation Expectations
According to public filings with capital markets regulator Securities and Exchange Board of India (SEBI), the public offer consists of:
Fresh Issue Component: Shares aggregating up to ₹8,001.57 crore.
Offer for Sale (OFS): Up to 2.16 crore equity shares (valued at approximately ₹1,275 crore) by existing shareholders, including promoter group entities and private equity investors.
Total Issue Size: Estimated at ₹9,276.78 crore at the upper end of the price band.
The minimum bid lot size for retail investors is set at 25 shares, translating to a minimum investment of ₹14,750 per application. The equity shares have a face value of ₹2 each.
Utilization of Funds and Debt Reduction
The primary proceeds raised through the fresh issue component are earmarked for debt management and strategic growth.
According to official filings, ₹5,378 crore will be directed toward prepaying or repaying outstanding borrowings of its material subsidiary, Manipal Hospitals Private Limited. An additional ₹574 crore is designated for acquiring a minority stake in step-down subsidiary Sahyadri Hospitals Private Limited.
Official Sources Section
Statements, regulatory filings, and timeline metrics have been cited according to official releases from SEBI, the National Stock Exchange of India (NSE), and the BSE Limited.
Legal documentation, including the Red Herring Prospectus (RHP), was prepared in consultation with lead managers Axis Capital Limited, Goldman Sachs (India) Securities, J.P. Morgan India, Jefferies India, Kotak Mahindra Capital, UBS Securities India, and DBS Bank India.
Quote Section
"According to officials and regulatory filings submitted to market authorities, the capital raised from the fresh issuance will significantly optimize the group's balance sheet by deleveraging primary operating subsidiaries, while strengthening operational capacity across multi-specialty regional hubs."
Why It Matters
For Patients & Healthcare Sector: Capital influx accelerates hospital network expansions and technology integrations across tier-1 and tier-2 markets.
For Retail & Institutional Investors: The offering provides a direct gateway to participate in India's expanding healthcare infrastructure, backed by prominent institutional investors like Temasek.
For Equity Markets: A public issue of this scale signals renewed liquidity and strong institutional appetite in the Indian primary market.
Key Facts at a Glance
IPO Bidding Dates: July 29, 2026 – July 31, 2026.
Price Band: ₹560 to ₹590 per equity share.
Lot Size & Investment: 25 shares per lot (Minimum investment ₹14,750).
Expected Listing Date: August 5, 2026, on both NSE and BSE.
Share Registrar: KFin Technologies Limited.
Frequently Asked Questions
When will the allotment status for the IPO be finalized?
The basis of share allotment is tentatively expected to be finalized on August 3, 2026, with refunds and credit of shares to demat accounts initiated by August 4, 2026.
What is the lot size structure for Non-Institutional Investors (NII/HNI)?
Small NIIs (sHNI) require a minimum application of 14 lots (350 shares) totaling ₹2,06,500, while Big NIIs (bHNI) require a minimum of 68 lots (1,700 shares) totaling ₹10,03,000.
Which exchanges will list the Manipal Health equity shares?
The shares are proposed to be listed on both the BSE Limited and the National Stock Exchange of India (NSE).
Source: Official Red Herring Prospectus (RHP), regulatory disclosures submitted to BSE Limited and National Stock Exchange of India, and public releases by the Securities and Exchange Board of India (SEBI).